期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

体液性排斥反应的靶向B淋巴细胞治疗 被引量：1

原文传递
导出
摘要 器官移植术后B淋巴细胞活化产生的抗体导致移植物损伤,在体液性排斥反应启动和发展过程中发挥主导作用.笔者曾撰文,结合国内外文献讨论B淋巴细胞活化与抗体介导的移植物排斥反应.
作者 石炳毅
机构地区 解放军第三
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2010年第10期580-583,共4页 Chinese Journal of Organ Transplantation
关键词 体液性排斥反应 淋巴细胞活化 细胞治疗 移植物排斥反应 靶向 抗体介导 移植物损伤 移植术后
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献18

  • 1石炳毅.B淋巴细胞活化与抗体介导的排斥反应[J].中华器官移植杂志,2010,31(6):321-324. 被引量：1
  • 2Glotz D,Antoine C,Julia P,et al.Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins(IVIG).Am J Transplant,2002,(2):758-760.
  • 3Anthony RM,Nimmerjahn F,Ashline DJ,et al.Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fe.Science,2008,320(5874):373-376.
  • 4Vieira CA,Agarwal A,Book BK,et al.Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation:1.Safety,pharmacodynamics,and pharmacokinetics1.Transplantation,2004,77(4):542-548.
  • 5Sidner RA,Book BK,Agarwal A,et al.In vivo human B-cell subset recovery after in vivo depletion with rituximab,antihuman CD20 monoclonal antibody.Hum Antibodies,2004,13(3):55-62.
  • 6Ashley VA,Peng A,Toyoda M,et al.Comparison of desensitization using high-dose(HD) IVIG vs.HD-IVIG + Rituximab in highly-sensitized patients with PRAs > eighty percent(HS).Am J Transplant,2010,10 Suppl 4:S221-222.
  • 7Okamoto M,Koshino K,Nobori S,et al.The excellent shortterm outcomes of ABO-incompatible living kidney transplantation using anti-CD20,CD25 antibody without splenectomy and IVIG.Am J Transplant,2010,10 Suppl 4:S223.
  • 8Habicht A,Broeker V,Richter N,et al.ABO-incompetible kidney transplantation-hannover experience.Am J Transplant,2010,10 Suppl 4:S225.
  • 9Shirakawa H,Ishida H,Shimizu T,et al.The low dose rituximab preconditioning in ABO-incompatible kidney transplantation.:a 3-year follow-up.Am J Transplant,2010,10 Suppl 4:S319.
  • 10Neubert K,Meister S,Moser K,et al.The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupuslike disease from nephritis.Nat Med,2008,14(7):748-755.

二级参考文献14

  • 1Colvin RB, Smith RN. Antibody-mediated organ allograft rejection. Nat Rev Immunol, 2005,5 (10) : 8(17-817.
  • 2Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity,2002,16(2) : 219-230.
  • 3Loder F, Mutschler B, Ray R J, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell reeeptor~derived signals. J Exp Med, 1999,190 (1):75 -89.
  • 4Amano M, Baumgarth N, Dick MD, et al. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen:beta 2-microglobulin-dependent and independent forms. J Immunol, 1998,161 (4) : 1710-1717.
  • 5Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol, 2002, 3 (10) :944-950.
  • 6Yanaba K, Bouaziz JD, Matsushita T, et al. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol, 2009,182 ( 12), 7459-7472.
  • 7Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation:new concepts in diagnosis and treatment. Curt Opin Nephrol Hypertens, 2002,11 ( 6 ) : 61}9-618.
  • 8Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by CAd deposits in peritubular capillaries. J Am Soc Nephrol,2001, 12(3) :574-582.
  • 9Bauer S,Groh V,Wu J ,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 1999,285(5428) :727- 729.
  • 10Zou Y, Mirbaha F, Lazaro A, et al. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol, 2002, 63 ( 1 ) : 30-39.

同被引文献36

  • 1宋继勇,石炳毅,杜国盛,金海龙,戴新,齐宝玉.治疗肝移植术后顽固性排斥反应的新尝试[J].中华器官移植杂志,2006,27(4):196-197. 被引量：3
  • 2Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation[J]. Nat Rev Immunol, 2012, 12 (6): 417- 430.
  • 3Lee KM, Stott RT, Zhao G, ct al. TGF-13-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance[J]. Eur J Immunol, 2014, 44 (6) : 1728-1736.
  • 4Manjarrez-Ordufio N, Qudch TD, Sanz I. B cells and immunological tolerance [ J]. J Invest Dermatol, 2009, 129 (2) : 278-288.
  • 5Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity[ J]. Curr Opin Immunol, 2008, 20 (3) : 332-338.
  • 6Mizoguehi A, Bhan AK. A case for regulatory B ceils [ J]. J Immmol, 2006, 176 (2) : 705-710.
  • 7Matsumura Y, Byme SN, Nghiem DX, et al. A Role for inflammatory mediators in the induction of immunoregulatory B Cells[J]. Jlmmmol, 2006, 177 (7): 4810-4817.
  • 8Bouaziz JD, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4 ( + ) T-cell activation in vitro[J]. EurJ Immunol, 2010, 40 (10): 2686-2691.
  • 9Blair PA, Norefia LY, Flores-Borja F, et al. CD19 ( + ) CD24 (hi) CD38 (hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients[ J]. Immunity, 2010, 32 (1) : 129-140.
  • 10Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare 1L-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells[J]. Blood, 2011, 117 (2) : 530-541.

引证文献1

二级引证文献1

中华器官移植杂志
2010年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部